1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. SPRUCE BIOSCIENCES INC
Spruce Biosciences Inc XNAS: SPRB

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Spruce Biosciences Inc

The latest disclosure was made by Javier Szwarcberg in Spruce Biosciences Inc where a trade of 39,605 Common Stock done at an average price of $0.4 was reported to US exchanges on Dec. 10, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Javier Szwarcberg Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. 10 Dec 2024 39,605 467,191 - 0.4 15,394 Common Stock
Charlton Ralph William CHIEF MEDICAL OFFICER 10 Dec 2024 37,964 123,809 - 0.5 20,387 Common Stock
Javier Szwarcberg Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. 10 Dec 2024 32,005 395,796 - 0.4 12,440 Common Stock
Szwarcberg Javier Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 358,800 358,800 - - Restricted Stock Units
M. Gharib Samir PRESIDENT AND CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 37,250 74,500 - - Restricted Stock Units
Gharib M. Samir PRESIDENT AND CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 38,500 115,500 - - Restricted Stock Units
Ralph Charlton William CHIEF MEDICAL OFFICER 10 Dec 2024 106,400 161,773 - 0 Common Stock
Javier Szwarcberg Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 111,000 506,796 - 0 Common Stock
M. Gharib Samir PRESIDENT AND CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. 10 Dec 2024 13,737 326,591 - 0.4 5,340 Common Stock
Ralph Charlton William CHIEF MEDICAL OFFICER 10 Dec 2024 11,329 161,339 - 0.4 4,404 Common Stock
Ralph Charlton William CHIEF MEDICAL OFFICER 10 Dec 2024 26,600 150,409 - 0 Common Stock
William Charlton Ralph CHIEF MEDICAL OFFICER 10 Dec 2024 106,400 106,400 - - Restricted Stock Units
Javier Szwarcberg Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 111,000 222,000 - - Restricted Stock Units
Szwarcberg Javier Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. 10 Dec 2024 128,020 338,101 - 0.5 68,747 Common Stock
Charlton Ralph William CHIEF MEDICAL OFFICER 10 Dec 2024 9,491 140,918 - 0.4 3,689 Common Stock
Ralph William Charlton CHIEF MEDICAL OFFICER 10 Dec 2024 31,750 172,668 - 0 Common Stock
Javier Szwarcberg Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 358,800 466,121 - 0 Common Stock
Javier Szwarcberg Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 89,700 427,801 - 0 Common Stock
Samir M. Gharib PRESIDENT AND CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 37,250 363,841 - 0 Common Stock
Gharib Samir M. PRESIDENT AND CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 38,500 340,328 - 0 Common Stock
M. Samir Gharib PRESIDENT AND CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 154,000 356,776 - 0 Common Stock
Ralph Charlton William CHIEF MEDICAL OFFICER 10 Dec 2024 26,600 79,800 - - Restricted Stock Units
Samir Gharib M. PRESIDENT AND CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 154,000 154,000 - - Restricted Stock Units
Gharib Samir M. PRESIDENT AND CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.54 per share. 10 Dec 2024 54,948 301,828 - 0.5 29,507 Common Stock
Gharib M. Samir PRESIDENT AND CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.39 per share. 10 Dec 2024 13,291 350,550 - 0.4 5,166 Common Stock
William Charlton Ralph CHIEF MEDICAL OFFICER 10 Dec 2024 31,750 63,500 - - Restricted Stock Units
Szwarcberg Javier Director, CHIEF EXECUTIVE OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Dec 2024 89,700 269,100 - - Restricted Stock Units
Daniel K. Spiegelman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Michael G. Grey Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Tiba Aynechi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Bali Muralidhar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Percival Barretto-Ko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Kirk Ways Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2024 30,000 30,000 - - Stock Option (Right to Buy)
Samir M. Gharib PRESIDENT AND CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2024 154,000 154,000 - - Restricted Stock Units
Javier Szwarcberg Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Mar 2024 358,800 358,800 - - Restricted Stock Units
Ralph William Charlton CHIEF MEDICAL OFFICER 14 Mar 2024 106,400 106,400 - - Restricted Stock Units
William Ralph Charlton Chief Medical Officer 29 Dec 2023 9,361 55,373 - 1.0 9,150 Common Stock
Samir M. Gharib President & CFO Grant, award, or other acquisition of securities at price $ 0.98 per share. 29 Dec 2023 11,255 202,776 - 1.0 11,002 Common Stock
M. Samir Gharib President & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 308,000 308,000 - - Restricted Stock Units
Javier Szwarcberg Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 717,600 717,600 - - Restricted Stock Units
Samir M. Gharib President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 75,000 75,000 - - Restricted Stock Units
Javier Szwarcberg Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 111,000 145,705 - 0 Common Stock
Samir Gharib M. President & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. 14 Dec 2023 23,213 167,153 - 1.7 38,534 Common Stock
Samir Gharib M. President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 37,250 111,750 - - Restricted Stock Units
Szwarcberg Javier Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. 14 Dec 2023 38,384 107,321 - 1.7 63,717 Common Stock
Gharib M. Samir President & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.66 per share. 14 Dec 2023 12,882 191,521 - 1.7 21,384 Common Stock
Szwarcberg Javier Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 111,000 333,000 - - Restricted Stock Units
M. Samir Gharib President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 37,250 204,403 - 0 Common Stock
Gharib M. Samir President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 75,000 190,366 - 0 Common Stock
William Charlton Ralph Chief Medical Officer 14 Dec 2023 212,800 212,800 - - Restricted Stock Units
Charlton Ralph William Chief Medical Officer 14 Dec 2023 10,980 46,012 - 1.7 18,227 Common Stock
William Charlton Ralph Chief Medical Officer 14 Dec 2023 31,750 56,992 - 0 Common Stock
William Ralph Charlton Chief Medical Officer 14 Dec 2023 31,750 95,250 - - Restricted Stock Units
Samir M. Gharib President & CFO Grant, award, or other acquisition of securities at price $ 0.98 per share. 30 Jun 2023 10,484 66,302 - 1.0 10,248 Common Stock
Samir M. Gharib President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 75,000 150,000 - - Restricted Stock Units
Samir M. Gharib President & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.15 per share. 30 Jun 2023 25,936 115,366 - 2.1 55,762 Common Stock
Samir M. Gharib President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2023 75,000 141,302 - - Common Stock
Javier Szwarcberg Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.98 per share. 30 Jun 2023 20,000 34,705 - 1.0 19,550 Common Stock
Ralph William Charlton Chief Medical Officer 30 Jun 2023 12,378 25,242 - 1.0 12,099 Common Stock
Daniel K. Spiegelman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 30,000 30,000 - - Stock Option (Right to Buy)
Tiba Aynechi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 30,000 30,000 - - Stock Option (Right to Buy)
Niall O’Donnell Director 25 May 2023 30,000 30,000 - - Stock Option (Right to Buy)
Bali Muralidhar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 30,000 30,000 - - Stock Option (Right to Buy)
Percival Barretto-Ko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 60,000 60,000 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 30,000 30,000 - - Stock Option (Right to Buy)
Kirk Ways Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2023 30,000 30,000 - - Stock Option (Right to Buy)
Niall O’Donnell Director 16 Feb 2023 472,800 472,800 - - Common Stock Warrant (Right to Buy)
Niall O’Donnell Director 16 Feb 2023 630,400 1,326,305 - 3.2 1,998,368 Common Stock
Samir M. Gharib President & CFO Grant, award, or other acquisition of securities at price $ 1.00 per share. 03 Jan 2023 1 33,611 - 1 1 Common Stock
Samir M. Gharib President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2023 37,500 225,000 - - Restricted Stock Units
Samir M. Gharib President & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. 03 Jan 2023 15,293 55,818 - 1.2 17,587 Common Stock
Samir M. Gharib President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jan 2023 37,500 71,111 - - Common Stock
Javier Szwarcberg Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.93 per share. 30 Dec 2022 14,705 14,705 - 0.9 13,717 Common Stock
Ralph William Charlton Chief Medical Officer 30 Dec 2022 12,864 12,864 - 0.9 12,000 Common Stock
Samir M. Gharib President & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2022 149,000 149,000 - - Restricted Stock Units
Javier Szwarcberg Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Dec 2022 444,000 444,000 - - Restricted Stock Units
Ralph William Charlton Chief Medical Officer 05 Dec 2022 127,000 127,000 - - Restricted Stock Units
Samir M. Gharib President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2022 37,500 262,500 - - Restricted Stock Units
Samir M. Gharib President & CFO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2022 37,500 41,132 - - Common Stock
Samir M. Gharib President & CFO Grant, award, or other acquisition of securities at price $ 1.48 per share. 30 Jun 2022 5,446 46,578 - 1.5 8,055 Common Stock
Samir M. Gharib President & CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.74 per share. 30 Jun 2022 12,968 33,610 - 1.7 22,564 Common Stock
Daniel K. Spiegelman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 22,500 22,500 - - Stock Option (Right to Buy)
Tiba Aynechi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 22,500 22,500 - - Stock Option (Right to Buy)
Niall O’Donnell Director 25 May 2022 22,500 22,500 - - Stock Option (Right to Buy)
Bali Muralidhar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 22,500 22,500 - - Stock Option (Right to Buy)
Dina Chaya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 22,500 22,500 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 22,500 22,500 - - Stock Option (Right to Buy)
Kirk Ways Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 May 2022 20,625 20,625 - - Stock Option (Right to Buy)
Javier Szwarcberg Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 250,000 250,000 - - Employee Stock Option (right to buy)
Javier Szwarcberg Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 750,000 750,000 - - Employee Stock Option (right to buy)
Samir M. Gharib Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2021 300,000 300,000 - - Restricted Stock Units
Samir M. Gharib Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2021 145,000 145,000 - - Employee Stock Option (right to buy)
Rosh Dias Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2021 75,000 75,000 - - Employee Stock Option (right to buy)
Rosh Dias Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2021 20,000 20,000 - - Restricted Stock Units
Samir M. Gharib Chief Financial Officer Other type of transaction at price $ 9.53 per share. 30 Jun 2021 1,412 1,412 - 9.5 13,454 Common Stock
Kirk Ways Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Apr 2021 14,045 2,007 - - Stock Option (Right to Buy)
Camilla V. Simpson Director Sale of securities on an exchange or to another person at price $ 16.14 per share. 30 Apr 2021 14,045 0 - 16.1 226,664 Common Stock
Camilla V. Simpson Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. 30 Apr 2021 14,045 14,045 - 0.8 11,938 Common Stock
Samir M. Gharib Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 55,000 55,000 - - Stock Option (Right to Buy)
Rosh Dias Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Jan 2021 27,500 27,500 - - Stock Option (Right to Buy)
Niall O’Donnell Director 14 Oct 2020 445,905 445,905 - - Common Stock
Niall O’Donnell Director 14 Oct 2020 2,916,664 0 - - Series B Preferred Stock
Niall O’Donnell Director 14 Oct 2020 250,000 695,905 - 15 3,750,000 Common Stock
Bali Muralidhar Director 14 Oct 2020 10,416,666 0 - - Series B Preferred Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 14 Oct 2020 200,000 1,792,518 - 15 3,000,000 Common Stock
Bali Muralidhar Director 14 Oct 2020 1,592,518 1,592,518 - - Common Stock
Dina Chaya Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 14 Oct 2020 250,000 2,161,022 - 15 3,750,000 Common Stock
Dina Chaya Director 14 Oct 2020 12,500,000 0 - - Series B Preferred Stock
Dina Chaya Director 14 Oct 2020 1,911,022 1,911,022 - - Common Stock
Jonas Hansson Director 14 Oct 2020 1,783,621 1,783,621 - - Common Stock
Jonas Hansson Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 14 Oct 2020 250,000 2,033,621 - 15 3,750,000 Common Stock
Jonas Hansson Director 14 Oct 2020 11,666,666 0 - - Series B Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters